These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 351417)

  • 1. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.
    Gryglewski RJ; Korbut R; Ocetkiewicz A
    Nature; 1978 Jun; 273(5665):765-7. PubMed ID: 351417
    [No Abstract]   [Full Text] [Related]  

  • 2. Almitrine increases plasma fibrinolytic activity through the release of prostacyclin from lungs into circulation.
    Korbut R; Byrska-Danek A; Gryglewski RJ
    Pharmacol Res Commun; 1982 Nov; 14(10):959-65. PubMed ID: 6760210
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of human platelet aggregation by stable analogs of prostacyclin.
    Togna G; GAndolfi C; Andreoni A; Fumagalli A; Passarotti C; Faustini F; Patrono C
    Pharmacol Res Commun; 1977 Nov; 9(10):909-16. PubMed ID: 343117
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
    Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
    [No Abstract]   [Full Text] [Related]  

  • 5. Lungs as a generator of prostacyclin--hypothesis on physiological significance.
    Gryglewski RJ; Korbut R; Ocetkiewicz A; Spławiński J; Wojtaszek B; Swies J
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Aug; 304(1):45-50. PubMed ID: 357998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of prostacyclin generation for modulation of vascular tone.
    Dusting GJ; Moncada S; Mullane KM; Vane JR
    Clin Sci Mol Med Suppl; 1978 Dec; 4():195s-198s. PubMed ID: 365431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of exogenous arachidonic acid to prostaglandins in the pulmonary circulation in vivo. A human and animal study.
    Nowak J; Radomski M; Kaijser L; Gryglewski RJ
    Acta Physiol Scand; 1981 Aug; 112(4):405-11. PubMed ID: 7032215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The road to prostacyclin.
    Vane JR
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():11-9. PubMed ID: 2936071
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac prostacyclin release: stimulation by hypoxia and various agents.
    Kirstein A
    Scand J Haematol Suppl; 1979; 34():105-11. PubMed ID: 384504
    [No Abstract]   [Full Text] [Related]  

  • 10. The lung as a generator of prostacyclin.
    Gryglewski RJ
    Ciba Found Symp; 1980; 78():147-64. PubMed ID: 7009095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall.
    Blajchman MA; Senyi AF; Hirsh J; Surya Y; Buchanan M; Mustard JF
    J Clin Invest; 1979 May; 63(5):1026-35. PubMed ID: 376547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet actions of stable carbocyclic analogues of prostacyclin.
    Whittle BJ; Moncada S
    Circulation; 1985 Dec; 72(6):1219-25. PubMed ID: 3905049
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-aggregatory effect of prostacyclin (PGI2) in vivo.
    Bayer BL; Blass KE; Förster W
    Br J Pharmacol; 1979 May; 66(1):10-2. PubMed ID: 378308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxin inhibits prostacyclin release by the rat pregnant myometrium.
    Williams KI; El Tahir KE
    Prostaglandins; 1982 Aug; 24(2):129-36. PubMed ID: 6815714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of partially obstructed coronary arteries with platelet thrombi: comparison between its prevention with cyclooxygenase inhibitors versus prostacyclin.
    Aiken JW; Shebuski RJ; Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 7():635-9. PubMed ID: 6245568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased prostacyclin release from perfused hearts of acutely diabetic rats.
    Rösen P; Schrör K
    Diabetologia; 1980 May; 18(5):391-4. PubMed ID: 7000593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some biochemical activities of 10,10-difluoro-13-dehydroprostacyclin, a chemically stable analog of prostacyclin, in human blood platelets.
    Harris DN; Phillips MB; Michel IM; Goldenberg HJ; Haslanger MF; Antonaccio MJ; Fried J
    Thromb Res; 1981 Aug 15-Sep 1; 23(4-5):387-99. PubMed ID: 6275567
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostacyclin is a circulating hormone.
    Moncada S; Korbut R; Bunting S; Vane JR
    Nature; 1978 Jun; 273(5665):767-8. PubMed ID: 351418
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin II-induced renal prostacyclin release suppresses platelet aggregation in the anesthetized dog.
    Shebuski RJ; Aiken JW
    Adv Prostaglandin Thromboxane Res; 1980; 7():1149-52. PubMed ID: 6989184
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacology of prostacyclin].
    Imai S
    Kokyu To Junkan; 1985 Jul; 33(7):845-9. PubMed ID: 2997894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.